Thiazolidineodiones, or simply “glitazones,” belong to a class of compounds that activates PPARγ and can be employed to treat type 2 diabetes and metabolic syndrome (Sauer, 2015). The gene discussed is PPARG; the disease is type 2 diabetes mellitus.